Valeant Pharmaceuticals International Inc.

Canada
Company NameValeant Pharmaceuticals International Inc.
Websitewww.valeant.com
Executive 1Rajiv De Silva, President; Division Officer;
Revenue (Millions)$3,547
Total Equity (Millions)$3,717
Net Income (Millions)$-116
Revenue Growth43.97%
Profit Margin 1(3.27%)
Earnings per Share($0.38)
Debt to Equity Ratio2.83%
Return on Equity(2.9%)
Cost of Goods Sold (Millions)$1,039
Earnings per Share Growth(177.55%)
Total Assets (Millions)$17,950
Current Liabilities (Millions)$1,823
Long Term Debt (Millions)$10,535